| 1 |
Harden RN. Chronic neuropathic pain. Mechanisms, diagnosis, and treatment. Neurologist. 2005, 11(2): 111-122
|
| 2 |
Cope DK,Lariviere WR. Gene therapy and chronic pain. Sci World J2006, 31(6): 1066-1074.
|
| 3 |
Hellon RF,Misra NK. Neurones in the dorsal horn of the rat responding to scrotal skin temperature changes. J Physiol, 1973, 232(2): 375- 388.
|
| 4 |
McMahon SB,Malcangio M. Current challenges in glia-pain biology. Neuron, 2009, 64(1): 46-54.
|
| 5 |
Hutchinson MR,Bland ST,Johnson KW. Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. Scientific World Journal, 2007, 2(7): 98-111.
|
| 6 |
Zahradnik HP,Hanjalic-Beck A,Groth K. Nonsteroidal anti-inflammatory drugs and hormonal contraceptives for pain relief from dysmenorrhea: a review Contraception, 2010, 81(3): 185-196.
|
| 7 |
Nishiyori M,Ueda H. Prolonged gabapentin analgesia in an experimental mouse model of fibromyalgia. Mol Pain, 2008, 6(4): 52.
|
| 8 |
Sawynok J,Esser MJ,Reid AR. Antide pressants as analgesics:anoverview of central and peripheral mechanisms of action. J Psychiatry Neurosci, 2001, 26(1): 21-29.
|
| 9 |
De Vry J,Kuhl E,Franken-Kunkel P. Pharmacological characterization of the chronic constriction injury model of neuropathic pain. Eur J Pharmacol, 2004, 491(2-3): 137-148.
|
| 10 |
Eaton MJ. Cell and molecular approaches to the attenuation of pain after spinal cord injury.J Neurotrauma, 2006, 23(3-4): 549-559
|
| 11 |
Michale wicz P,Launrito CE. Purificatin of adrenal chromaffin cells in creases antinociceptive efficacy xenotransplants without immumosuppression. Cell Transplant, 1999, 8(2): 103-109.
|
| 12 |
Lazorthes Y,Sagen J,Sallerin B, et al. Human chromaffin cell graft into the CNS for cancer pain management: a prospective phase Ⅱclinical study. Pain, 2000, 87(1): 19-21.
|
| 13 |
Pappas GD,Laxothes Y,Bes JC, et al. Relief of intractable cancer pain by human chromaffin cell transplants: experience at two medical centres. Neural Res, 1997, 19(1): 71-73.
|
| 14 |
Eaton MJ,Herman JP,Jullien N, et al. Immortalized chromaffin cells disimmortalized with Cre/Lox site-direccted recombination for use in cell therapy for pain after partial nerve injury. Experimental Neurology, 2002, 175(1): 49-60.
|
| 15 |
Zou WY,Guo QL,Yang Y. Analgesic effect of intrathecal injection of Herpes simplex virus type I amplicon vector-mediated human preproenkephalin gene on chronic neuropathic pain: experiment with rats. Zhonghua Yi Xue Za Zhi, 2008, 88(29): 2064-2068.
|
| 16 |
Eaton MJ,Blits B,Ruitenberg MJ. Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV) vector-mediated over-expression of BDNF in the rat spinal cord. Gene Ther, 2002, 9(20): 1387-1395.
|